Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoadjuvant Operable Breast Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8936 Neoplasms 6859 Carcinoma, Non-Small-Cell Lung 5019 Prostatic Neoplasms 4431 Colorectal Neoplasms 4015 Lung Neoplasms 3250 Leukemia, Myeloid, Acute 2709 Neoplasm Metastasis 2702 Multiple Myeloma 2686 Pancreatic Neoplasms 2507 Melanoma 2333 Lymphoma 2275 Ovarian Neoplasms 2258 Carcinoma, Hepatocellular 2169 Stomach Neoplasms 2051 Recurrence 1943 Head and Neck Neoplasms 1832 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1819 Lymphoma, Non-Hodgkin 1805 Leukemia 1792 Brain Neoplasms 1703 Glioblastoma 1596 Colonic Neoplasms 1565 Leukemia, Lymphocytic, Chronic, B-Cell 1542 Rectal Neoplasms 1508 Uterine Cervical Neoplasms 1456 Lymphoma, Follicular 1428 Squamous Cell Carcinoma of Head and Neck 1427 Lymphoma, Large B-Cell, Diffuse 1393 Carcinoma, Renal Cell 1369

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡